📣 VC round data is live. Check it out!

Burjeel Holdings Valuation Multiples

Discover revenue and EBITDA valuation multiples for Burjeel Holdings and similar public comparables like Agilon Health, Almoosa Health, Dr Agarwals, Aevis Victoria and more.

Burjeel Holdings Overview

About Burjeel Holdings

Burjeel Holdings PLC is a healthcare service provider. Along with its subsidiaries, it provides multi-specialty hospitals, medical, surgical and dental services, and the sale of pharmaceutical goods and medical equipment. The group's reportable segments are Hospitals, Medical Centre, Pharmacies, and Others. Maximum revenue for the group is derived from the Hospitals segment, which includes entities that provide inpatient, day-care services, and outpatient services to patients to diagnosis the disease and offer medical and surgical treatment as part of in-patient services. Geographically, it derives maximum revenue from its customers in the United Arab Emirates, followed by the Sultanate of Oman and the Kingdom of Saudi Arabia.


Founded

2020

HQ

United Arab Emirates

Employees

12.3K

Financials (LTM)

Revenue: $2B
EBITDA: $289M

EV

$2B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Burjeel Holdings Financials

Burjeel Holdings reported last 12-month revenue of $2B and EBITDA of $289M.

In the same LTM period, Burjeel Holdings generated $289M in EBITDA and $119M in net income.

Revenue (LTM)


Burjeel Holdings P&L

In the most recent fiscal year, Burjeel Holdings reported revenue of $1B and EBITDA of $295M.

Burjeel Holdings is profitable as of last fiscal year, with gross margin of 31%, EBITDA margin of 20%, and net margin of 9%.

See analyst estimates for Burjeel Holdings
LTMLast FY202320242025202620272028
Revenue$2B$1B$1B$1B$1B
Gross Profit-$461M$402M$404M$461M
Gross Margin-31%33%30%32%
EBITDA$289M$295M$281M$247M$295M
EBITDA Margin19%20%23%18%20%
EBIT Margin12%12%15%11%12%
Net Profit$119M$129M$141M$95M$129M
Net Margin8%9%12%7%9%
Net Debt-$447M---

Financial data powered by Morningstar, Inc.

Burjeel Holdings Stock Performance

Burjeel Holdings has current market cap of $2B, and enterprise value of $2B.

Market Cap Evolution


Burjeel Holdings' stock price is $0.29.

Burjeel Holdings share price increased by 1.0% in the last 30 days, and decreased by 25.4% in the last year.

Burjeel Holdings has an EPS (earnings per share) of $0.02.

See more trading valuation data for Burjeel Holdings
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$2B$2B0.0%1.0%-18.5%-25.4%$0.02

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Burjeel Holdings Valuation Multiples

Burjeel Holdings trades at 1.5x EV/Revenue multiple, and 7.8x EV/EBITDA.

See NTM and 2027E valuation multiples for Burjeel Holdings

EV / Revenue (LTM)


Burjeel Holdings Financial Valuation Multiples

As of May 30, 2026, Burjeel Holdings has market cap of $2B and EV of $2B.

Burjeel Holdings has a P/E ratio of 12.6x.

LTMLast FY202320242025202620272028
EV/Revenue1.5x1.5x1.9x1.7x1.6x
EV/EBITDA7.8x7.7x8.1x9.2x7.7x
EV/EBIT12.7x12.9x12.7x15.3x12.9x
EV/Gross Profit-4.9x5.6x5.6x4.9x
P/E12.6x11.6x10.7x15.9x11.6x
EV/FCF-(45.6x)21.5x34.1x(45.6x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Burjeel Holdings Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Burjeel Holdings Margins & Growth Rates

Burjeel Holdings grew revenue by 7% but EBITDA decreased by 1% in the last fiscal year.

In the most recent fiscal year, Burjeel Holdings reported gross margin of 31%, EBITDA margin of 20%, and net margin of 9%.

See estimated margins and future growth rates for Burjeel Holdings

Burjeel Holdings Margins

Last FY202420252026202720282029
Gross Margin31%30%32%-
EBITDA Margin20%18%20%18%
EBIT Margin12%11%12%12%
Net Margin9%7%9%7%
FCF Margin(3%)5%(3%)-

Burjeel Holdings Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth7%10%8%11%
Gross Profit Growth-0%14%-
EBITDA Growth(1%)(12%)20%(1%)
EBIT Growth7%(17%)19%7%
Net Profit Growth(10%)(33%)37%(10%)
FCF Growth-(37%)(175%)-

Data powered by FactSet, Inc. and Morningstar, Inc.

Burjeel Holdings Operational KPIs

Burjeel Holdings' revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

Burjeel Holdings' Rule of 40 is 29% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Burjeel Holdings' Rule of X is 46% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Burjeel Holdings
LTMLast FY202320242025202620272028
Rule of 4027%29%---
Bessemer Rule of X40%46%---
Revenue per Employee-$0.1M---
Opex per Employee-$0.0M---
S&M Expenses to Revenue-2%1%2%2%
G&A Expenses to Revenue-1%1%1%1%
Opex to Revenue-19%18%19%20%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Burjeel Holdings Competitors

Burjeel Holdings competitors include Agilon Health, Almoosa Health, Dr Agarwals, Aevis Victoria, Ramsay Santé, Med Life, Ardent Health, OdontoPrev, Park Medi World and Siloam Hospitals.

Most Burjeel Holdings public comparables operate across Hospitals & Clinics.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Agilon Health0.2x0.2x(4.5x)(8.1x)
Almoosa Health4.3x4.2x17.0x-
Dr Agarwals7.7x7.5x26.2x27.4x
Aevis Victoria1.7x1.9x23.8x20.4x
Ramsay Santé0.9x-8.4x-
Med Life2.9x2.3x20.3x15.9x
Ardent Health0.5x0.5x5.5x5.7x
OdontoPrev-3.3x-10.4x

This data is available for Pro users. Sign up to see all Burjeel Holdings competitors and their valuation data.

Start Free Trial

Burjeel Holdings M&A Activity

Burjeel Holdings has acquired 1 company to date.

Last acquisition by Burjeel Holdings was on February 17th 2025. Burjeel Holdings acquired Advanced Care Oncology Center for $31M (EV/Revenue multiple of ).

See M&A valuation multiples

Latest Acquisitions by Burjeel Holdings

Advanced Care Oncology Center
Description
Advanced Care Oncology Center is a Dubai-based facility delivering radiation therapy, nuclear medicine, and chemotherapy for cancer patients. Located in Jumeirah Lake Towers, it operates advanced linear accelerators and PET-CT scanners for precise diagnostics and treatments. The center serves the UAE market with multidisciplinary teams handling breast, lung, and prostate cancers among others. It maintains accreditation from international bodies and integrates palliative care services.
HQ CountryUnited Arab Emirates
HQ City
Dubai
Deal Date17 Feb 2025
Valuation$31M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Burjeel Holdings acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Burjeel Holdings

When was Burjeel Holdings founded?Burjeel Holdings was founded in 2020.
Where is Burjeel Holdings headquartered?Burjeel Holdings is headquartered in United Arab Emirates.
How many employees does Burjeel Holdings have?As of today, Burjeel Holdings has over 12K employees.
Is Burjeel Holdings publicly listed?Yes, Burjeel Holdings is a public company listed on Abu Dhabi Securities Exchange.
What is the stock symbol of Burjeel Holdings?Burjeel Holdings trades under BURJEEL ticker.
When did Burjeel Holdings go public?Burjeel Holdings went public in 2022.
Who are competitors of Burjeel Holdings?Burjeel Holdings main competitors include Agilon Health, Almoosa Health, Dr Agarwals, Aevis Victoria, Ramsay Santé, Med Life, Ardent Health, OdontoPrev, Park Medi World, Siloam Hospitals.
What is the current market cap of Burjeel Holdings?Burjeel Holdings' current market cap is $2B.
What is the current revenue of Burjeel Holdings?Burjeel Holdings' last 12 months revenue is $2B.
What is the current revenue growth of Burjeel Holdings?Burjeel Holdings revenue growth (NTM/LTM) is 8%.
What is the current EV/Revenue multiple of Burjeel Holdings?Current revenue multiple of Burjeel Holdings is 1.5x.
What is the current EBITDA of Burjeel Holdings?Burjeel Holdings' last 12 months EBITDA is $289M.
What is Burjeel Holdings' EBITDA margin?Burjeel Holdings' last 12 months EBITDA margin is 19%.
What is the current EV/EBITDA multiple of Burjeel Holdings?Current EBITDA multiple of Burjeel Holdings is 7.8x.
How many companies Burjeel Holdings has acquired to date?As of May 2026, Burjeel Holdings has acquired 1 company.
What was the largest acquisition by Burjeel Holdings?$31M acquisition of Advanced Care Oncology Center on 17th February 2025 was the largest M&A Burjeel Holdings has done to date.
What companies Burjeel Holdings acquired?Burjeel Holdings acquired Advanced Care Oncology Center.
In how many companies Burjeel Holdings has invested to date?Burjeel Holdings hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Burjeel Holdings

Lists including Burjeel Holdings

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial